FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Fortrea Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.42−0.07 (-0.31%)
Close on Oct 19, 2026
- Market cap
- $2.13B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$12.97 (+137.2%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Fortrea Holdings Inc. saw revenue fall 2.1% to $2.68B over the twelve months to Jun 30, 2026. Free cash flow was $196.00M.
Revenue
$2.68B
-2.1% vs. a year earlier
Operating income
-$10.80M
TTM Q2 2026
Free cash flow
$196.00M
TTM Q2 2026
EPS, diluted
-$10.81
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.13B
- P/E ratio
- –
- Price to sales
- 0.79
- Price to book
- 4.05
- Dividend yield
- –
- Free cash flow yield
- 9.22%
Fundamentals
- Revenue
- $2.68B
- Net income
- -$85.20M
- EPS, diluted
- -$10.81
- Free cash flow
- $196.00M
- Book value per share
- $5.53
- Diluted shares
- 95M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$2.68B-2.1% YoY
Gross profit
$516.60M-4.2% YoY
Operating income
-$10.80M
Net income
-$85.20M
EPS, diluted
–
Free cash flow
$196.00M
Reported periodTrailing twelve months